Transforming Care in Cystic Fibrosis: The Long-Term Impact of Quality Improvement Projects on Clinical Outcomes
S Karabulut1, M Yuksel Kalyoncu1, M Selcuk Balcı1
1Department of Pediatrics, Division of Pediatric Pulmonology, Marmara University School of Medicine, Istanbul, Turkey.
Insights
A quality improvement program improved BMI in children with cystic fibrosis (CF) and maintained adult lung function over five years. These findings highlight the benefits of sustained QI efforts for CF patient outcomes.
Area of Science:
- Pulmonology
- Quality Improvement Science
- Pediatric Medicine
Background:
- Cystic Fibrosis (CF) requires ongoing management to optimize patient outcomes.
- Quality Improvement (QI) programs are essential for enhancing standard care in CF centers.
- Longitudinal data on the impact of QI in specific CF populations, like Turkish patients, is limited.
Purpose of the Study:
- To assess the 5-year impact of a structured QI program on body mass index (BMI) and lung function (FEV₁) in people with CF (pwCF).
- To evaluate changes in BMI z-scores and FEV₁ percent predicted (FEV₁pp) in pediatric and adult pwCF.
- To explore the association between BMI, lung function, and treatment burden.
Main Methods:
- Retrospective review of medical records for 440 pwCF from January 2018 to December 2022.
- Utilized data submitted to the European Cystic Fibrosis Society Patient Registry (ECFSPR).
- Employed linear mixed-effects regression models to analyze time-dependent changes in FEV₁pp.
Main Results:
- Significant improvement in BMI z-scores observed in pediatric pwCF (p < 0.001); adult BMI remained stable (p = 0.10).
- No significant linear change in mean FEV₁pp was detected in adjusted models (p > 0.05), but median FEV₁pp increased in adults.
- Higher BMI correlated with better lung function (p < 0.001) and reduced IV antibiotic use (p < 0.001 for children, p = 0.045 for adults).
- Estimated mean survival age for the cohort was 46.1 years.
Conclusions:
- This study presents the first 5-year longitudinal registry data and survival estimates for Turkish pwCF.
- Sustained, center-wide QI initiatives can maintain or improve clinical outcomes in CF care.
- QI programs are particularly valuable in settings with restricted access to CFTR modulators.
Objective:
This study aimed to evaluate 5-year outcomes of a structured quality improvement (QI) program implemented as part of the standard of care at our CF center, focusing on changes in body mass index (BMI) and forced expiratory volume in 1 s (FEV₁) in pwCF followed at our institution.
Methods:
The medical records of pwCF registered at our CF center between January 1, 2018, and December 31, 2022, were retrospectively reviewed. Demographic and clinical data of pwCF submitted by our center to the European Cystic Fibrosis Society Patient Registry (ECFSPR) were used for this analysis. Structured QI strategies were initiated in 2018 after collaboration with the University of Michigan CF Center and focused on nutrition, respiratory care, and treatment adherence. Time-dependent changes in FEV1 percent predicted (FEV1pp) were evaluated using a linear mixed-effects regression model.
Results:
All 440 pwCF followed at our center during the study period were included in the analysis. Over 5 years, BMI z-scores improved significantly in children (p < 0.001), while adult BMI remained stable (p = 0.10). No significant linear change in mean FEV₁pp was observed in adjusted longitudinal models (p > 0.05), however, descriptive analyses showed an increase in median FEV₁pp among adults. Higher BMI was associated with better lung function (p < 0.001) and lower IV antibiotic burden in correlation analyses (children: p < 0.001; adults: p = 0.045). The estimated mean survival age of the analysis cohort was 46.1 years.
Conclusion:
To our knowledge, this is the first report of a cohort of Turkish pwCF summarizing 5-year longitudinal registry data with survival estimates. These findings suggest that sustained, center-wide QI efforts may help maintain or improve clinical outcomes, particularly in settings with limited access to CFTR modulators.
Related Concept Videos
Cystic Fibrosis: Management
Sinus disease and chronic...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Health Information Technology and Healthcare Information System
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
Patient-centered Care
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment


